Ala-Quin Side Effects

Generic Name: clioquinol / hydrocortisone topical

Note: This page contains information about the side effects of clioquinol / hydrocortisone topical. Some of the dosage forms included on this document may not apply to the brand name Ala-Quin.

Not all side effects for Ala-Quin may be reported. You should always consult a doctor or healthcare professional for medical advice. Side effects can be reported to the FDA here.

For the Consumer

Applies to clioquinol / hydrocortisone topical: topical cream, topical ointment

In addition to its needed effects, some unwanted effects may be caused by clioquinol / hydrocortisone topical. In the event that any of these side effects do occur, they may require medical attention.

You should check with your doctor immediately if any of these side effects occur when taking clioquinol / hydrocortisone topical:

Rare
  • Blistering, burning, itching, peeling, skin rash, redness, swelling, or other sign of irritation not present before use of this medicine
With prolonged use
  • Thinning of skin with easy bruising

For Healthcare Professionals

Applies to clioquinol / hydrocortisone topical: topical cream, topical kit, topical ointment

Dermatologic

Burning; itching; irritation; dryness; folliculitis; blistering, peeling, redness, swelling; hypertrichosis; acneiform eruptions; hypopigmentation; perioral dermatitis; maceration of the skin, secondary infection; skin atrophy; striae; and miliaria or other signs of irritation not present before therapy have been reported with topical corticosteroids and clioquinol, especially under occlusive dressings.

Rare (less than 0.1%): Discoloration (yellowing) of hair and nails, irritating to sensitized skin
Frequency not reported: Rash; thinning of the skin with easy bruising; itching; burning; irritation; dryness; hypopigmentation; acneiform eruptions; skin atrophy; folliculitis; blistering, peeling, redness, swelling; hypertrichosis; perioral dermatitis; maceration of the skin, secondary infection; striae; miliaria or other signs of irritation not present before therapy

Hypersensitivity

Allergic contact dermatitis has been reported with topical corticosteroids and clioquinol, especially under occlusive dressings.

Frequency not reported: Hypersensitivity, allergic contact dermatitis

Endocrine

Clioquinol:
Frequency not reported: Interference with thyroid function tests, significant elevation of protein-bound iodine or butanol-extractable iodine, decrease in radioactive iodine uptake

Topical corticosteroids (systemic absorption):
Frequency not reported: Reversible hypothalamic-pituitary-adrenal axis suppression, manifestations of Cushing's syndrome

Metabolic

Topical corticosteroids (systemic absorption):
Frequency not reported: Hyperglycemia

Genitourinary

Topical corticosteroids (systemic absorption):
Frequency not reported: Glucosuria

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate safety, effectiveness, or appropriateness for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of materials provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the substances you are taking, check with your doctor, nurse, or pharmacist.

Hide
(web1)